It's time to take psilocybin seriously as a possible treatment for substance use disorders. Read More > August 24, 2016
Return of the psychedelics: Psilocybin for treatment resistant depression Read More > August 23, 2016
The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors Read More > August 17, 2016
Urinary and plasma oxytocin changes in response to MDMA or intranasal oxytocin administration Read More > August 16, 2016
